Why the study?
Does Danggui buxue tang (DBT) improve renal function and metabolic parameters in streptozotocin-induced diabetic rats?
Does Danggui buxue tang (DBT) improve renal function and metabolic parameters in streptozotocin-induced diabetic rats?
Danggui buxue tang may slow the progression of diabetic nephropathy in rats by suppressing TGF-beta1 mRNA expression, independent of the renin-angiotensin system.
Answers are grounded in this paper and cite their sources.
No clinical data available on DBT; leaves open any renal benefit in human diabetic nephropathy.
Danggui buxue tang (DBT), a preparation containing Angelica sinensis (danggui) and Astragalus membranaceus (huangqi) at a ratio of 1 : 5, is used widely in China for stimulating red blood cell production and enhancing cardiovascular function. The present study was undertaken to characterize the effects of this preparation on diabetic nephropathy using streptozotocin-diabetic rats as a model. Streptozotocin-dependent alterations in renal weight/body weight ratio, urinary albumin and beta (2)-microglobulin concentrations, urinary albumin excretion rate, and creatinine clearance were ameliorated after eight weeks of treatment with either DBT or the angiotensin-converting enzyme inhibitor, benazepril. DBT, but not benazepril, partially attenuated the increases in blood glucose, triglycerides and cholesterol in STZ-diabetic rats. Additionally, the increased expression of transforming growth factor-beta (1) mRNA in the renal cortex due to streptozotocin-induced diabetes was modestly attenuated by these treatments. However, eight weeks of treatment with DBT failed to modify the concentration of angiotensin II in plasma or kidney, indicating that the ability of the preparation to retard the progression of kidney disease was not attributable to inhibition of the renin-angiotensin system. We propose that DBT alleviates renal alterations in diabetes and slows the progression of diabetic nephropathy by suppressing transforming growth factor-beta (1) mRNA expression. The preparation may therefore be useful as an adjuvant therapy for controlling diabetes and its complications.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: